203 related articles for article (PubMed ID: 6685619)
1. Effect of prostaglandin E1 on vasoactive intestinal polypeptide release from the hypothalamus and on prolactin secretion from the pituitary in rats.
Shimatsu A; Kato Y; Matsushita N; Katakami H; Ohta H; Yanaihara N; Imura H
Endocrinology; 1983 Dec; 113(6):2059-64. PubMed ID: 6685619
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin D2 stimulates vasoactive intestinal polypeptide release into rat hypophysial portal blood.
Shimatsu A; Kato Y; Matsushita N; Ohta H; Kabayama Y; Yanaihara N; Imura H
Peptides; 1984; 5(2):395-8. PubMed ID: 6591147
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactive vasoactive intestinal polypeptide in rat hypophysial portal blood.
Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
Endocrinology; 1981 Feb; 108(2):395-8. PubMed ID: 7449730
[TBL] [Abstract][Full Text] [Related]
4. Stimulation by serotonin of vasoactive intestinal polypeptide release into rat hypophysial portal blood.
Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
Endocrinology; 1982 Jul; 111(1):338-40. PubMed ID: 7084118
[TBL] [Abstract][Full Text] [Related]
5. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
Mogg RJ; Samson WK
Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
[TBL] [Abstract][Full Text] [Related]
6. Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells.
Hagen TC; Arnaout MA; Scherzer WJ; Martinson DR; Garthwaite TL
Neuroendocrinology; 1986; 43(6):641-5. PubMed ID: 3762862
[TBL] [Abstract][Full Text] [Related]
7. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
Michalkiewicz M; Suzuki M; Kato M
Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
[TBL] [Abstract][Full Text] [Related]
9. Galanin stimulates the release of vasoactive intestinal polypeptide from perifused hypothalamic fragments in vitro and from periventricular structures into the cerebrospinal fluid in vivo in the rat.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Feb; 85(1):95-100. PubMed ID: 2452388
[TBL] [Abstract][Full Text] [Related]
10. Central galanin stimulates pituitary prolactin secretion in rats: possible involvement of hypothalamic vasoactive intestinal polypeptide.
Koshiyama H; Kato Y; Inoue T; Murakami Y; Ishikawa Y; Yanaihara N; Imura H
Neurosci Lett; 1987 Mar; 75(1):49-54. PubMed ID: 2437498
[TBL] [Abstract][Full Text] [Related]
11. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
[TBL] [Abstract][Full Text] [Related]
12. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
[TBL] [Abstract][Full Text] [Related]
13. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
Gómez O; Balsa JA
Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
[TBL] [Abstract][Full Text] [Related]
14. Involvement of hypothalamic vasoactive intestinal polypeptide (VIP) in prolactin secretion induced by serotonin in rats.
Shimatsu A; Kato Y; Ohta H; Tojo K; Kabayama Y; Inoue T; Yanaihara N; Imura H
Proc Soc Exp Biol Med; 1984 Apr; 175(4):414-6. PubMed ID: 6709640
[TBL] [Abstract][Full Text] [Related]
15. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
[TBL] [Abstract][Full Text] [Related]
16. Evidence for prolactin feedback actions on hypothalamic oxytocin, vasoactive intestinal peptide and dopamine secretion.
Sarkar DK
Neuroendocrinology; 1989 May; 49(5):520-4. PubMed ID: 2498758
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of prolactin secretion in rhesus monkeys by vasoactive intestinal polypeptide.
Frawley LS; Neill JD
Neuroendocrinology; 1981 Aug; 33(2):79-83. PubMed ID: 7266772
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic factors involved in the endogenous stimulatory rhythm regulating prolactin secretion.
Arey BJ; Freeman ME
Endocrinology; 1989 Feb; 124(2):878-83. PubMed ID: 2521468
[TBL] [Abstract][Full Text] [Related]
19. Intraventricular administration of histidyl-proline-diketopiperazine [Cyclo(His-Pro)] suppresses prolactin secretion and synthesis: a possible role of Cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus.
Jikihara H; Ikegami H; Koike K; Wada K; Morishige K; Kurachi H; Hirota K; Miyake A; Tanizawa O
Endocrinology; 1993 Mar; 132(3):953-8. PubMed ID: 7679984
[TBL] [Abstract][Full Text] [Related]
20. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
Carrillo AJ; Phelps CJ
Endocrinology; 1992 Aug; 131(2):964-9. PubMed ID: 1639033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
